Published June 4, 2021, 2:28 PM
In this file photo taken on February 12, 2021, a vial containing the Covid-19 vaccine by AstraZeneca and a syringe are seen on a table in the pharmacy of the vaccination center at the Robert Bosch Hospital in Stuttgart, southern Germany. (Photo by THOMAS KIENZLE / AFP / MANILA BULLETIN)
The Department of Health (DOH) said it will look into the possibility of shortening the interval between the first and second doses of AstraZeneca COVID-19 vaccine.
DOH Undersecretary Maria Rosario Vergeire made the statement amid the United Kingdom’s decision to shorten the gap between the two doses of AstraZeneca vaccine to eight weeks.
The AstraZeneca COVID-19 vaccine is 97 percent effective against the India strain of the coronavirus.
In this file photo taken on February 12, 2021, a vial containing the Covid-19 vaccine by AstraZeneca and a syringe are seen on a table in the pharmacy of the vaccination center at the Robert Bosc
Nationwide network to improve animal welfare and research is launchedAnimal experiments contribute to a better understanding of diseases in medicine and help in the development of many new diagnostic procedures and therapies. Despite the development
N.Y. Hospitalizations Fall; U.S. Shots Go Unused: Virus Update Bloomberg 1 hr ago Bloomberg News
(Bloomberg) Many U.S. states and cities have a growing surplus of Covid-19 vaccines, a sign that in some places demand is slowing before a large percentage of the population has been inoculated, according to a Bloomberg analysis. New York state hospitalizations dropped below 4,000 for the first time since Dec. 1.
Global production of Covid-19 vaccines surpassed 1 billion doses this week and will likely reach 2 billion in a little more than a month, according to a forecast from research company Airfinity Ltd. Merck & Co. halted development of two experimental drugs for patients hospitalized with Covid-19.